| BCBS Oklahoma Medical Policies | Depemokimab-ulaa | 2026-09-01 |
| UHC Medicare Advantage | Deep Brain and Responsive Cortical Stimulation – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Skilled Nursing Facility, Rehabilitation, Long-Term Acute Care Hospital, and Private Duty Nursing – Medicare Advantage Medical Policy | 2026-09-01 |
| HealthPartners | Prosthesis - upper limb | 2026-09-01 |
| BCBS Highmark Delaware | Pegloticase (Krystexxa) | 2026-09-01 |
| BCBS Highmark Delaware | Omalizumab (Xolair) and Omalizumab Biosimilars | 2026-09-01 |
| Humana Medicare Advantage | Injections for Pain Conditions - Medicare Advantage | 2026-09-01 |
| BCBS Massachusetts | Ambulatory electroencephalogram (EEG) Monitoring | 2026-09-01 |
| BCBS Massachusetts | Gene Therapies for Spinal Muscular Atrophy (SMA) | 2026-09-01 |
| UHC Surest Medical and Drug | Intravenous Iron Replacement Therapy (Injectafer® & Monoferric®) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-09-01 |